Clinical target sequencing for precision medicine of breast cancer-Reference-Cited by-同舟云学术

Clinical target sequencing for precision medicine of breast cancer

Published:2019-01-02 Issue:2 Volume:24 Page:131-140
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Tsuchida Junko,Rothman Jami,McDonald Kerry-Ann,Nagahashi Masayuki^ORCID,Takabe Kazuaki,Wakai Toshifumi

Funder

Japan Society for the Promotion of Science

Takeda Science Foundation

NIH/NCI grant

Susan G. Komen Investigator Initiated Research Grant

Tohoku Cancer Professional Training Promotion Plan

Denka Co., Ltd

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

http://link.springer.com/article/10.1007/s10147-018-1373-5/fulltext.html

Reference89 articles.

1. Siegel RL, Miller KD, Jemal A (2017) Cancer statistics, 2017. CA Cancer J Clin 67:7–30

2. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365:1687–1717

3. Katsnelson A (2013) Momentum grows to make ‘personalized’ medicine more ‘precise’. Nat Med 19:249

4. Yurkiewicz S (2010) The prospects for personalized medicine. Hastings Cent Rep 40:14–16

5. The White House Office of the Press Secretary (2015) Fact sheet: President Obama’s precision medicine initiative. Available via DIALOG. https://obamawhitehouse.archives.gov/the-press-office/2015/01/30/fact-sheet-president-obama-s-precision-medicine-initiative . Accessed July 2018

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma Metabolome Signatures to Predict Responsiveness to Neoadjuvant Chemotherapy in Breast Cancer;Cancers;2024-07-06

2. YRNA and tRNA fragments can differentiate benign from malignant canine mammary gland tumors;Biochemical and Biophysical Research Communications;2024-01

3. Cell cycle arrest and apoptotic studies of Terminalia chebula against MCF-7 breast cancer cell line: an in vitro and in silico approach;Frontiers in Oncology;2023-08-29

4. Copy number alteration is an independent prognostic biomarker in triple-negative breast cancer patients;Breast Cancer;2023-03-17

5. In Silico Identification of Genes Associated with Breast Cancer Progression and Prognosis and Novel Therapeutic Targets;Biomedicines;2022-11-21